User profiles for Christine Johnston
Christine JohnstonUniversity of Washington Verified email at u.washington.edu Cited by 6964 |
[HTML][HTML] Homologous and heterologous Covid-19 booster vaccinations
Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …
have received emergency use authorization in the United States are highly effective, …
[PDF][PDF] Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …
Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
To explore the mechanism by which herpes simplex virus (HSV)-2 infection is related to HIV-1
acquisition, we conducted in situ analysis of the cellular infiltrate from sequential biopsies …
acquisition, we conducted in situ analysis of the cellular infiltrate from sequential biopsies …
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection
E Tronstein, C Johnston, ML Huang, S Selke… - Jama, 2011 - jamanetwork.com
Context Since herpes simplex virus type 2 (HSV-2) antibody tests have become commercially
available, an increasing number of persons have learned that they have genital herpes …
available, an increasing number of persons have learned that they have genital herpes …
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection
Most herpes simplex virus 2 (HSV-2) reactivations in humans are subclinical and associated
with rapid expansion and containment of virus. Previous studies have shown that CD8 + T …
with rapid expansion and containment of virus. Previous studies have shown that CD8 + T …
Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo
…, NV Giannakopoulos, LJ Gunn, C Johnston… - Journal of …, 2005 - Am Soc Microbiol
The innate immune response, and in particular the alpha/beta interferon (IFN-α/β) system,
plays a critical role in the control of viral infections. Interferons α and β exert their antiviral …
plays a critical role in the control of viral infections. Interferons α and β exert their antiviral …
Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding
C Johnston, L Corey - Clinical microbiology reviews, 2016 - Am Soc Microbiol
Herpes simplex virus 2 (HSV-2) is a DNA virus that is efficiently transmitted through intimate
genital tract contact and causes persistent infection that cannot be eliminated. HSV-2 may …
genital tract contact and causes persistent infection that cannot be eliminated. HSV-2 may …
[HTML][HTML] Heterologous SARS-CoV-2 booster vaccinations–preliminary report
Background: While Coronavirus disease 2019 (Covid-19) vaccines are highly effective,
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
breakthrough infections are occurring. Booster vaccinations have recently received emergency …
Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial
…, HC Stankiewicz Karita, C Johnston… - Annals of internal …, 2021 - acpjournals.org
Background: Effective prevention against coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently limited to …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently limited to …
[HTML][HTML] Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients
No therapeutic agent has yet been established as the definitive therapy for adenovirus infections.
We describe the clinical experience of 13 immunocompromised patients who received …
We describe the clinical experience of 13 immunocompromised patients who received …